Trisalus Life Sciences Stock Today

TLSI Stock   5.32  0.25  4.93%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
TriSalus Life is trading at 5.32 as of the 29th of June 2025. This is a 4.93% up since the beginning of the trading day. The stock's open price was 5.07. TriSalus Life has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 31st of March 2025 and ending today, the 29th of June 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
10th of August 2023
Category
Healthcare
Classification
Health Care
TriSalus Life is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 37.98 M outstanding shares of which 119.69 K shares are at this time shorted by private and institutional investors with about 2.91 trading days to cover. More on TriSalus Life Sciences

Moving against TriSalus Stock

  0.47ISRG Intuitive Surgical Sell-off TrendPairCorr
  0.44HAE HaemoneticsPairCorr
  0.43CAH Cardinal HealthPairCorr
  0.43NVNO enVVeno Medical CorpPairCorr
  0.38NVST Envista Holdings CorpPairCorr
  0.36DH Definitive HealthcarePairCorr

TriSalus Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President CEOMBA BSN
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.291.2278
Sufficiently Up
Slightly volatile
Gross Profit Margin0.640.8606
Way Down
Slightly volatile
Total Current Liabilities12.7 M10.2 M
Fairly Up
Slightly volatile
Non Current Liabilities Total37.7 M39.6 M
Notably Down
Slightly volatile
Total Assets21.9 M24 M
Significantly Down
Slightly volatile
Total Current Assets18.8 M20.7 M
Moderately Down
Slightly volatile
Debt Levels
TriSalus Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand TriSalus Life's financial leverage. It provides some insight into what part of TriSalus Life's total assets is financed by creditors.
Liquidity
TriSalus Life Sciences currently holds 23.63 M in liabilities. Note, when we think about TriSalus Life's use of debt, we should always consider it together with its cash and equity.

Free Cash Flow

(43.25 Million)
TriSalus Life Sciences (TLSI) is traded on NASDAQ Exchange in USA. It is located in 6272 West 91st Avenue, Westminster, CO, United States, 80031 and employs 110 people. TriSalus Life is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 202.03 M. TriSalus Life Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 37.98 M outstanding shares of which 119.69 K shares are at this time shorted by private and institutional investors with about 2.91 trading days to cover. TriSalus Life generates negative cash flow from operations
Check TriSalus Life Probability Of Bankruptcy
Ownership Allocation
TriSalus Life Sciences shows a total of 37.98 Million outstanding shares. TriSalus Life Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check TriSalus Ownership Details

TriSalus Life Historical Income Statement

As of now, TriSalus Life's Interest Expense is increasing as compared to previous years. The TriSalus Life's current Research Development is estimated to increase to about 22.8 M, while Net Interest Income is forecasted to increase to (2.6 M). View More Fundamentals

TriSalus Stock Against Markets

TriSalus Life Corporate Management

Rachel GarciaMarketing ManagerProfile
Bryan CoxChief ResearchProfile
Dan GiordanoActing FinanceProfile
Jennifer JDChief OfficerProfile
Alan MendelsonSecretaryProfile
Lori SantamariaVice OperationsProfile
When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.10)
Revenue Per Share
1.207
Quarterly Revenue Growth
0.42
Return On Assets
(0.86)
Return On Equity
(4.96)
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.